9 results
8-K
EX-99.1
ONCR
Oncorus, Inc.
9 Nov 21
Regulation FD Disclosure
8:10am
Exhibit 99.1
Oncorus Announces Details of Upcoming ONCR-177 Phase 1 Initial Clinical Data Presentation at the Society for Immunotherapy of Cancer’s … at the upcoming Society for Immunotherapy of Cancer’s (SITC) 36th Annual Meeting, taking place November 12–14, 2021 in Washington, D.C. and virtually. ONCR
8-K
EX-99.1
ONCR
Oncorus, Inc.
21 Jun 21
Oncorus Appoints Eric Rubin, M.D. to its Board of Directors
4:03pm
and American Cancer Society study sections, as well as on program committees for the American Association of Cancer Research (AACR) and the American … Society of Clinical Oncology. He is a co-chair of the Cancer Steering Committee of the Biomarkers Consortium, Foundation of the National Institute
8-K
ONCR
Oncorus, Inc.
9 Nov 21
Regulation FD Disclosure
8:10am
upcoming presentation at the Society for Immunotherapy of Cancer’s 2021 Annual Meeting and that it will host an upcoming investor call and webcast
8-K
EX-99.1
ONCR
Oncorus, Inc.
12 Nov 21
Entry into a Material Definitive Agreement
7:45am
at the Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting, taking place November 12-14th in Washington, D.C. and virtually. In the fully
8-K
EX-99.1
ONCR
Oncorus, Inc.
9 Mar 22
Oncorus Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Updates
7:46am
Presented initial data from ongoing Phase 1 clinical trial of ONCR-177 at the Society for Immunotherapy of Cancer's (SITC) 36th Annual Meeting
8-K
EX-99.1
si0uew5zb0gf1eyi
3 Nov 21
Oncorus Reports Third Quarter 2021 Financial Results and Provides Business Updates
7:18am
8-K
y54kgp5ozt7zti8iy0t
12 Nov 21
Entry into a Material Definitive Agreement
7:45am
424B5
gvvf96v8txsx pperylc
19 Nov 21
Prospectus supplement for primary offering
4:41pm
- Prev
- 1
- Next